A new MedTech innovation programme in Glasgow aims to help turn ideas in medical technology into real products that can be used in healthcare. It is designed to help students move from learning to actually creating and launching new solutions.
Experts say the programme could help develop the next generation of Scottish health innovations and make them successful around the world.
A key partner, InnoScot Health, says the University of Glasgow’s new MedTech Innovation Master’s will be the leading course of its kind in Scotland. It is expected to help connect education with real-world practice and put Scotland on the global map for medical innovation.
The university’s cutting-edge programme — developed in collaboration with innovation hubs, industry pioneers, and NHS Greater Glasgow & Clyde — addresses real-world challenges through healthcare technology, and InnoScot Health is certain it will break down barriers to frontline adoption.
Executive Chair, Graham Watson said: “This is an important step in bringing Scotland’s NHS, industry, and academia closer together while fostering a stronger homegrown pipeline of leading MedTech innovation.
“The programme represents a significant piece in the puzzle for accelerating promising early-stage ideas into commercial reality through a clearly defined, comprehensive learning pathway.
“We further believe it could help to spearhead next generation Scottish solutions on a global scale, enhancing accessibility to cutting-edge tech solutions for improved patient outcomes while transforming economic growth.”
The University of Glasgow says the MSc will start in September, offering an opportunity to “be part of the world changing generation that revolutionises patient care using technology” and will leverage digital, data, and AI technologies for forward-thinking solutions.
The 12-month programme positions its participants “at the intersection of healthcare, technology, and business,” equipping them with knowledge of the entire MedTech innovation lifecycle.
This moves from honing the ability to identify unmet clinical needs, through to designing and developing solutions, navigating regulatory challenges, implementation, commercialisation, and scaling.
The programme also offers placement opportunities to gain valuable experience with NHS bodies, government organisations, and leading MedTech companies.
Programme partners are:
- The West of Scotland Innovation Hub (WoSIH)
- NHS Greater Glasgow and Clyde
- SafeHaven
- The National Robotarium
- Scottish Ambulance Service
- Industry leaders at both national and global stage, including Scottish SMEs and spinouts such as Tile Bio and Lumino
I am so excited to share the MedTech Innovation Masters programme which covers healthcare innovation opportunity identification and end to end evidence generation as part of a route to get MedTech products safely to market.
Katriona Brooksbank, Innovation Lead at the West of Scotland Innovation Hub
Graham added: “Academia is often where inspiration begins and early-stage ideas are formed with Glasgow undoubtedly at the heart of Scotland’s high-value, increasingly convergent MedTech ecosystem, encompassing medical devices, digital health, and in vitro diagnostics.
“Indeed, Dr David Brennan, the CEO of one of our own spinouts, Aurum Biosciences, studied Clinical Physics at the University of Glasgow, before joining NHS Greater Glasgow and Clyde, and is now leading an internationally ambitious company which is targeting areas of significant medical need.
“InnoScot Health provided critical regulatory support to Aurum early in its innovation journey and continues to play a key role across Scotland’s MedTech ecosystem in ensuring innovations have the necessary regulatory clearances as they reach market readiness.”
Global statistics
- Revenue in the Medical Technology market is projected to reach US$666.25bn in 2026.
- The market’s largest market is Medical Devices with a projected market volume of US$571.72bn in 2026.
- Revenue is expected to show an annual growth rate (CAGR 2026-2030) of 5.52%, resulting in a market volume of US$826.04bn by 2030.
- In global comparison, most revenue will be generated United States (US$245.21bn in 2026).
06.05.2026.
